The world’s largest commercially focused ATMP event is making its way online


May 19-21, 2021

Coming to you live, wherever you are

BOOK NOW
Find out about Sponsor opportunities

What is Advanced Therapies?

Advanced Therapies 2021 brings together the life science community to meet, do business and solve the challenges preventing ATMPs getting to market and saving patient lives.

Join us online this May.   Get Involved

 120 expert presenters  |  3 virtual channels  |  9 content themes  |  50 sponsors  |  50 start-ups  |  2000+ attendees  |  Interactive panels, workshops and open discussions  |  121 meetings  | 

2021 speakers

 

Alexander Natz
Secretary General
European Confederation of Pharmaceutical Entrepreneurs (EUCOPE)
Alexander Natz speaking at Advanced Therapies Congress
Amir Hefni
Vice President and Global Commercial Head for Cell & Gene
Novartis
Amir Hefni speaking at Advanced Therapies Congress
Angela Columbano
Director of Business and Development
Genethon
Angela Columbano speaking at Advanced Therapies Congress
Birgitte Volck
Non-Executive Director
Soleno Therapeutics
Birgitte Volck speaking at Advanced Therapies Congress
Bradley Campbell
President and COO
Amicus Therapeutics
Bradley Campbell speaking at Advanced Therapies Congress
Daniel O’Mahony
Partner
Seroba Life Sciences
Daniel O’Mahony speaking at Advanced Therapies Congress
David Morrow
Senior Scientific Programme Manager-ATMP/Vaccines
EATRIS
David Morrow speaking at Advanced Therapies Congress
David Venables
President, AskBio Europe
AskBio
David Venables speaking at Advanced Therapies Congress
Detlev Parow
Head of Department of Medicines, Therapeutic Appliances and Remedies
DAK
Detlev Parow speaking at Advanced Therapies Congress
Dominic Schmidt
Partner
Dominic Schmidt
Dominic Schmidt speaking at Advanced Therapies Congress
Eric Michael David
CEO
BridgeBio Gene Therapy
Eric Michael David speaking at Advanced Therapies Congress
Jaap Boelens
Chief, Transplantion and Cellular Therapies, MSK Kids
Memorial Sloan Kettering Cancer Center
Jaap Boelens speaking at Advanced Therapies Congress
Jean-Philippe Combal
Co-Founder & CEO
Vivet Therapeutics
Jean-Philippe Combal speaking at Advanced Therapies Congress
John Maher
Consultant and Senior Lecturer in Immunology, King's College London, CSO
Leucid
Luc Boileau speaking at Advanced Therapies Congress
Kris Elverum
SVP, Business Development & Strategy
Rubius Therapeutics
Kris Elverum speaking at Advanced Therapies Congress
Larry Lamb
Executive Vice President / Chief Scientific Officer
In8bio
Larry Lamb speaking at Advanced Therapies Congress
Leslie Meltzer
Head of Medical Affairs
Orchard Therapeutics
Leslie Meltzer speaking at Advanced Therapies Congress
Magali Taiel
CMO
GenSight Biologics
Magali Taiel speaking at Advanced Therapies Congress
Manuel Carrondo
Professor of Chemical & Biochemical Engineering, FCT-UNL, Vice-President
IBET
Manuel Carrondo speaking at Advanced Therapies Congress
Margareth Jorvid
Head of Regulatory Affairs and QA
Immunicum AB
Alexander Natz speaking at Advanced Therapies Congress
Miguel Forte
CEO
Bone Therapeutics
Miguel Forte speaking at Advanced Therapies Congress
Moshe Israeli
Medical Director
Rabin Medical Center
Moshe Israeli speaking at Advanced Therapies Congress
Paolo Morgese
EU Director Market Access & Member Relations
Alliance for Regenerative Medicine
Paolo Morgese speaking at Advanced Therapies Congress
Pascal Touchon
President, CEO & Member of the Board
Atara Biotherapeutics
Pascal Touchon speaking at Advanced Therapies Congress
Peter Marks
Director, Center For Biologics Evaluation and Research (CBER)
FDA
Peter Marks speaking at Advanced Therapies Congress
Philip J. Brooks
Program Director, Office of Rare Diseases Research, National Center for Advancing Translational Sciences (NCATS)
National Institutes of Health
Philip J. Brooks speaking at Advanced Therapies Congress
Pierre-Albert Colcomb
Director Business Development
Genethon
Pierre-Albert Colcomb speaking at Advanced Therapies Congress
Prasad Adusumilli
Deputy Chief And Associate Attending, Thoracic Surgery Director, Mesothelioma Program
Memorial Sloan-Kettering Cancer Center
Prasad Adusumilli speaking at Advanced Therapies Congress
Roy Baynes
Senior Vice President and Head Global Clinical Development, Chief Medical Officer
Merck Research Laboratories
Roy Baynes speaking at Advanced Therapies Congress
Stefanos Theoharis
CBO
Bone Therapeutics
Stefanos Theoharis speaking at Advanced Therapies Congress
Steve Kanner
CSO
Caribou Biosciences
Steve Kanner speaking at Advanced Therapies Congress
Sven Kili
CMO, Xintela; Principle
Sven Kili Consulting
Sven Kili speaking at Advanced Therapies Congress

 

DOWNLOAD 2020 POST EVENT REPORT
 

Get Involved
Download the Advanced Therapies Prospectus

 

DOWNLOAD PROSPECTUS

 

 

Companies that attend Advanced Therapies

 

NovartisAstraZenecaAveXisAvrobioBellicumbluebird biobluerockCellectiscelyadchiesigenethonGileadGSKHistogenicsJuno Therapeutics, a Celgene CompanyLogicBioMSKCCMerck Research LaboaratoriesmesoblastNightstar TherapeuticsNHSOrchard TherapeuticsOxford BioMedicaPfizerPrecision BiosciencesSangamo TherapeuticssanofiSelecta BiosciencesSemma TherapeuticsSentien BiotechnologySigilon TehraptueicsSpark TherapeuticsTC BiopharmTelethonZelluna Immunotherapy
 

Join us online

Across the four days of the congress, we are bringing you 120 world leading speakers discussing cell therapy, gene therapy, evidence pricing and access and much more.

Find out more

Stay up to date on the latest Advanced Therapies Congress news

By submitting, you agree to receive email communications from Advanced Therapies Congress, including upcoming promotions and discounted tickets, news, and access to exclusive invite-only events.